An open observational safety study during administration of Topamac [topiramate], as monotherapy in epileptic patients with no prior treatment or unsuccessfully treated with other antiepileptic drug
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 13 Oct 2009 Actual patient number (80) added as reported by ClinicalTrials.gov.
- 20 Mar 2008 Status changed from in progress to completed based on information from the ClinicalTrials.gov site.
- 30 Jul 2007 Status changed from initiated to in progress